These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11536931)

  • 1. Similarity of urinary risk factors among stone-forming patients in five regions of the United States.
    Harvey JA; Hill KD; Pak CY
    J Lithotr Stone Dis; 1990 Apr; 2(2):124-32. PubMed ID: 11536931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
    Stuart RO 2nd ; Hill K; Poindexter J; Pak CY
    J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight, age and coefficients of variation in renal solute excretion.
    Perry GM; Scheinman SJ; Asplin JR
    Nephron Physiol; 2012; 122(1-2):13-8. PubMed ID: 23595094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing applicants to the NASA flight program for their renal stone-forming potential.
    Pak CY; Hill K; Cintron NM; Huntoon C
    Aviat Space Environ Med; 1989 Feb; 60(2):157-61. PubMed ID: 2930428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.
    Nishiura JL; Campos AH; Boim MA; Heilberg IP; Schor N
    Urol Res; 2004 Oct; 32(5):362-6. PubMed ID: 15221244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients Attending Shared Medical Appointments for Metabolic Stone Prevention Have Decreased Stone Risk Factors.
    Jhagroo RA; Nakada SY; Penniston KL
    J Endourol; 2016 Nov; 30(11):1262-1268. PubMed ID: 27673722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urolithiasis in adults. Clinical and biochemical aspects.
    Abdel-Halim RE
    Saudi Med J; 2005 May; 26(5):705-13. PubMed ID: 15951854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdependence of urinary factors in calcareous bladder stone patients.
    Singh PP; Pendse AK; Rathore V; Kiran R; Dashora PK
    Int Urol Nephrol; 1989; 21(2):145-51. PubMed ID: 2744986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.